Fitbit (NYSE: FIT) reported Q2 sales of $261.27 million. Earnings fell to a loss of $91.21 million, resulting in a 27.42% decrease from last quarter. In Q1, Fitbit brought in $188.16 million in sales but lost $125.67 million in earnings.What Is Return On Capital Employed? Changes in earnings and sales indicate shifts in Fitbit's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q2, Fitbit posted an ROCE of -0.21%.It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.View more earnings on FITROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows Fitbit is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.In Fitbit's case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.Q2 Earnings Insight Fitbit reported Q2 earnings per share at $-0.12/share, which beat analyst predictions of $-0.22/share.See more from Benzinga * Click here for options trades from Benzinga * Price Over Earnings Overview: Apple * ROCE Insights For Invesco Mortgage Capital(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Fitbit (NYSE: FIT) Fitbit announced today it has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly $2.5 million from the U.S. Department of Defense through a Medical Technology Enterprise Consortium (MTEC) award to advance development of a wearable diagnostic capability for the early detection of a COVID-19 infection. As part of the award, Fitbit is working to initiate a prospective study with Northwell Health’s Feinstein Institutes for Medical Research to validate a Fitbit COVID-19 early detection algorithm.
Fitbit (FIT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.